Provigil Pregnancy Use Linked To Increased Risk Of Birth Defects: Study
A new study warns that Provigil side effects may increase the risk of birth defects when taken during the first trimester of pregnancy.
Tag Archives: Teva
-
-
Lawsuits Over Hepatits C Outbreak From Propofol Settled for $250M
Teva Pharmaceuticals has agreed to pay $250 million to settle about 80 Propofol lawsuits stemming from a hepatitis C outbreak at Las Vegas endoscopy clinics.
-
Hepatitis C Damage Awards Against Teva, Baxter Continue to Pile Up
Teva Pharmaceuticals and Baxter International have been hit with a massive punitive damages award for a third time as a result of their role in causing a hepatitis C outbreak…
-
Ocella Lawsuit Filed Over Stroke Caused by Generic Yaz / Yasmin
A lawsuit has been filed in federal court claiming that Ocella birth control, a generic version of Bayer’s Yasmin and Yaz, caused an Iowa woman to suffer a stroke and…
-
Generic Seroquel Held Off by US Appeals Court
The U.S. Court of Appeals for the Federal Circuit has rejected attempts by generic drug makers to invalidate AstraZeneca’s patent on the atypical antipsychotic drug Seroquel, meaning that generic versions…
-
Generic Yasmin Lawsuit Appeal Invalidates Bayer Patent
A federal appeals court has invalidated Bayer’s patent for the birth control pill Yasmin, opening the door for Teva Pharmaceuticals to produce the generic version, Ocella, without licensing the drug.
-
Tardive Dyskinesia Lawsuit Filed Over Reglan in Arkansas
An Arkansas woman has filed a lawsuit against the manufacturers of Reglan over her development of tardive dyskinesia, a movement disorder that causes uncontrollable movements or ticks, which she alleges…
-
Reglan (Metoclopramide) Lawsuit Consolidation Being Considered Today
The U.S. Judicial Panel on Multidistrict Litigation is scheduled to hear oral arguments today about whether to consolidate all lawsuits involving Reglan and generic metoclopramide drugs, which have been linked…
-
Generic Reglan Lawsuit Appeal Request Denied in Vermont
Four generic drug makers named as defendants in a Reglan lawsuit pending in the U.S. District Court for the District of Vermont have been denied the opportunity to pursue an…
